new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Ardea Biosciences Inc
Ardea Biosciences Inc_20131212
  

Ardea Biosciences Inc patents

Recent patent applications related to Ardea Biosciences Inc. Ardea Biosciences Inc is listed as an Agent/Assignee. Note: Ardea Biosciences Inc may have other listings under different names/spellings. We're not affiliated with Ardea Biosciences Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Ardea Biosciences Inc-related inventors




Date Ardea Biosciences Inc patents (updated weekly) - BOOKMARK this page
12/29/16Treatment of gout
09/22/16Combinations of mek inhibitors and raf kinase inhibitors and uses thereof
09/01/16Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid and uses thereof
08/04/16Compounds, compositions and methods of using same for modulating uric acid levels
08/04/16Novel compounds and compositions and methods of use
07/28/16Manufacture of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid
05/26/16Treatment of gout and hyperuricemia
10/01/15Preparation of (r)-n-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (s)- n-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide
09/10/15Manufacture of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid
04/16/15Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid and uses thereof
04/02/15S-triazolyl alpha-mercapto acetanilides as inhibitors of hiv reverse transcriptase
10/09/14Polymorphic form of n-(s)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof
06/19/14Hypertension and hyperuricemia
05/08/14Compounds, compositions and methods of using same for modulating uric acid levels
03/20/14Pharmaceutical combinations for treatment of specific cancers
01/02/14Novel compounds and compositions and methods of use
12/26/13Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio) acetate, and uses thereof
12/12/13Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid and uses thereof
11/07/13Methods for treating hyperuricemia and related diseases
10/03/13Preparation of (r)-n-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (s)- n-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide
10/03/13Polymorphic form of n-(s)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof
08/08/13Thioacetate compounds, compositions and methods of use
08/08/13Thioacetate compounds, compositions and methods of use
07/11/13Treatment of gout and hyperuricemia
02/14/13Compounds, compositions and methods of using same for modulating uric acid levels
02/14/13Compounds, compositions and methods of using same for modulating uric acid levels
11/29/12Polymorphic form of n-(s)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof
11/08/12S-triazolyl alpha-mercapto acetanilides as inhibitors of hiv reverse transcriptase
09/06/12Substituted thienol[2,3-d] pyrimidines as hiv inhibitors
09/06/12Pyrrolo [2,3-d] pyrimidines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv
07/05/12Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid and uses thereof
07/05/12Androgen receptor antagonists and uses thereof
06/28/12Novel compounds and compositions and methods of use
05/31/12Methods of modulating uric acid levels
05/24/12Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio) acetate, and uses thereof
05/17/12Compounds, compositions and methods for modulating uric acid levels
05/03/12Dihydropyridin sulfonamides and dihydropyridin sulfamides as mek inhibitors
03/29/12N[s(4-aryl-triazol-3-yl)alpha-mercaptoacetyl]-p-amino benzoic acids as hiv reverse transcriptase inhibitors
03/22/12Pharmaceutical combinations comprising for the treatment of specific cancers
03/01/12Treatment of pancreatic cancer
12/22/11S-triazolyl alpha-mercapto acetanilides as inhibitors of hiv reverse transcriptase
12/01/11Novel compounds and compositions and methods of use
11/03/11Novel compounds and compositions and methods of use
11/03/11Novel compositions and methods of use
10/06/11Compositions comprising 4-(2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetamido)-3-chlorobenzoic acid and pharmaceutically acceptable salts thereof, and methods for preparing and using same
08/04/11S-triazole alpha- mercaptoacetanilides as inhibitors of hiv reverse transcriptase
03/10/11Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same
02/10/11Compositions and methods for preparing and using same
10/21/10S-triazole alpha-mercaptoacetanilides as inhibitors of hiv reverse transcriptase
06/03/10N[s(4-aryl-triazol-3-yl)alpha-mercaptoacetyl] -p-amino benzoic acids as hiv reverse transcriptase inhibitors
04/01/102-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid and methyl ester
09/10/09Polymorphic form of n-(s)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl) cyclopropane-1-sulfonamide and uses thereof
08/06/09Novel compounds and compositions and methods of use
12/12/13Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid and uses thereof







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Ardea Biosciences Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ardea Biosciences Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';